CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT
Keyword(s):
De Novo
◽
Key Points Donor and/or recipient CMV seropositivity is still associated with an adverse prognosis in de novo acute leukemia patients after allo-SCT.
2019 ◽
Vol 25
(3)
◽
pp. S56
2020 ◽
Vol 55
(9)
◽
pp. 1763-1772
◽
2015 ◽
Vol 51
(3)
◽
pp. 351-357
◽
2018 ◽
Vol 93
(12)
◽
pp. 1532-1542
◽
2017 ◽
Vol 52
(4)
◽
pp. 592-599
◽